for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients

Aug 28 (Reuters) - Gilead Inc said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.

The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness. (reut.rs/31DfMIk) (Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up